Coronavirus Update

The U.S. biopharmaceutical industry is working closely with U.S. government agencies, the World Health Organization and governments around the world to identify their most pressing needs in the areas of vaccination, diagnostics, and antivirals and other treatments, and to facilitate collaborations with industry.

To learn more about what the biopharmaceutical industry is doing to combat the virus and for a host of information and helpful resources (FAQ’s, CDC Information Hub, Safety Tips, etc.)
Slider

Richard Giersch – Board Chairman
CEO
Valtari Bio

John Maher, Ph.D. – First Vice Chair
Vice President for Research, Marshall University
Executive Director, Marshall University Research Corporation

Brian Acklin
Regional Marketing Manager 
Medtronic Pain Therapies 

Anne Barth 
Executive Director
TechConnect West Virginia

Frank Binder, Ph.D.
President
Microbiological Consultants, Inc.

Allyson Blandford
Sr. Manager, State Government Affairs
Amgen

Todd Davies, Ph.D.
Director, Research Development & Translation
Marshall Clinical Research Center

David W, Fraser

Allie Karshenas, Ph.D.
Associate VP of Clinical Operations & Institutional Advancement
West Virginia University

Erienne Olesh, PhD
Director
Vantage Ventures

Matt Powell, Ph.D.
Matthew Powell, PhD
Associate Service Fellow
CDC/NIOSH/HELD/ACIB

Jeffrey P. Smith, Ph.D.
VP, Pharmacology and Toxicology
Mylan Laboratories, Inc.

Jagan Valluri, Ph.D.
Chief Operating Officer
Cordgenics

Executive Director
Bryan Brown

PO BOX 20065 | Charleston, WV 25362 | (304) 546-5500